William Plovanic
Stock Analyst at Canaccord Genuity
(3.29)
# 1,054
Out of 5,005 analysts
149
Total ratings
46.62%
Success rate
2.8%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANGO AngioDynamics | Maintains: Buy | $17 → $18 | $11.64 | +54.64% | 8 | Oct 3, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $131 → $132 | $97.32 | +35.64% | 11 | Oct 1, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $24 | $14.71 | +63.15% | 6 | Sep 29, 2025 | |
| DXCM DexCom | Maintains: Buy | $106 | $67.05 | +58.09% | 8 | Sep 29, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $170 → $193 | $175.61 | +9.90% | 12 | Sep 29, 2025 | |
| AORT Artivion | Maintains: Buy | $41 → $50 | $41.05 | +21.80% | 3 | Sep 29, 2025 | |
| PODD Insulet | Maintains: Buy | $353 → $399 | $309.12 | +29.08% | 5 | Sep 29, 2025 | |
| HTFL HeartFlow | Maintains: Buy | $35 → $39 | $37.64 | +3.61% | 2 | Sep 22, 2025 | |
| STIM Neuronetics | Maintains: Buy | $8 → $7 | $2.85 | +145.61% | 4 | Aug 6, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $75 → $81 | $77.07 | +5.10% | 27 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $60.48 | +48.81% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $129 → $142 | $115.69 | +22.74% | 6 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $100.78 | +0.22% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $18 | $8.71 | +106.66% | 8 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 | $4.62 | +138.10% | 4 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $52 | $34.81 | +49.38% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $12.64 | +161.08% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $7.02 | +113.68% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $256.06 | +10.91% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $13.96 | +79.08% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.84 | +552.17% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $84.21 | -16.87% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $27.14 | +76.86% | 5 | Aug 3, 2023 |
AngioDynamics
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $11.64
Upside: +54.64%
Boston Scientific
Oct 1, 2025
Maintains: Buy
Price Target: $131 → $132
Current: $97.32
Upside: +35.64%
Tandem Diabetes Care
Sep 29, 2025
Maintains: Buy
Price Target: $24
Current: $14.71
Upside: +63.15%
DexCom
Sep 29, 2025
Maintains: Buy
Price Target: $106
Current: $67.05
Upside: +58.09%
iRhythm Technologies
Sep 29, 2025
Maintains: Buy
Price Target: $170 → $193
Current: $175.61
Upside: +9.90%
Artivion
Sep 29, 2025
Maintains: Buy
Price Target: $41 → $50
Current: $41.05
Upside: +21.80%
Insulet
Sep 29, 2025
Maintains: Buy
Price Target: $353 → $399
Current: $309.12
Upside: +29.08%
HeartFlow
Sep 22, 2025
Maintains: Buy
Price Target: $35 → $39
Current: $37.64
Upside: +3.61%
Neuronetics
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $2.85
Upside: +145.61%
Edwards Lifesciences
Jul 25, 2025
Maintains: Hold
Price Target: $75 → $81
Current: $77.07
Upside: +5.10%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $60.48
Upside: +48.81%
Jul 15, 2025
Maintains: Buy
Price Target: $129 → $142
Current: $115.69
Upside: +22.74%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $100.78
Upside: +0.22%
Apr 8, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $8.71
Upside: +106.66%
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $4.62
Upside: +138.10%
Mar 28, 2025
Maintains: Buy
Price Target: $66 → $52
Current: $34.81
Upside: +49.38%
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $12.64
Upside: +161.08%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $7.02
Upside: +113.68%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $256.06
Upside: +10.91%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $13.96
Upside: +79.08%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.84
Upside: +552.17%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $84.21
Upside: -16.87%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $27.14
Upside: +76.86%